These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17695473)

  • 1. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
    Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
    Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
    Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ
    Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake.
    Ulrich CM; Bigler J; Whitton JA; Bostick R; Fosdick L; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):875-82. PubMed ID: 11489754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
    Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study].
    Yu WP; Chen K; Ma XY; Yao KY; Jiang QT; Zou Y; Zhou HG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):162-6. PubMed ID: 15182482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
    Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
    Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes.
    Kiss I; Sándor J; Pajkos G; Bogner B; Hegedüs G; Ember I
    Anticancer Res; 2000; 20(1B):519-22. PubMed ID: 10769717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia.
    Pakakasama S; Mukda E; Sasanakul W; Kadegasem P; Udomsubpayakul U; Thithapandha A; Hongeng S
    Am J Hematol; 2005 Jul; 79(3):202-5. PubMed ID: 15981231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.
    Huang WY; Chatterjee N; Chanock S; Dean M; Yeager M; Schoen RE; Hou LF; Berndt SI; Yadavalli S; Johnson CC; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):152-7. PubMed ID: 15668489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A1 genetic polymorphisms and in situ colorectal cancer.
    Sivaraman L; Leatham MP; Yee J; Wilkens LR; Lau AF; Le Marchand L
    Cancer Res; 1994 Jul; 54(14):3692-5. PubMed ID: 7913406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene.
    Abdel-Rahman SZ; El-Zein RA; Ammenheuser MM; Yang Z; Stock TH; Morandi M; Ward JB
    Environ Mol Mutagen; 2003; 41(2):140-6. PubMed ID: 12605384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.